Home Cart Sign in  
Chemical Structure| 1025065-69-3 Chemical Structure| 1025065-69-3

Structure of SGI-1776 free base
CAS No.: 1025065-69-3

Chemical Structure| 1025065-69-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

SGI-1776 free base is an ATP competitive inhibitor of Pim1 with IC50 of 7 nM in a cell-free assay, 50- and 10-fold selective versus Pim2 and Pim3, also potent to Flt3 and haspin.

Synonyms: SGI-1776; Pim-Kinase Inhibitor IX

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of SGI-1776 free base

CAS No. :1025065-69-3
Formula : C20H22F3N5O
M.W : 405.42
SMILES Code : FC(F)(F)OC1=CC(C2=CN=C3C=CC(NCC4CCN(C)CC4)=NN32)=CC=C1
Synonyms :
SGI-1776; Pim-Kinase Inhibitor IX
MDL No. :MFCD16659064
InChI Key :MHXGEROHKGDZGO-UHFFFAOYSA-N
Pubchem ID :24795070

Safety of SGI-1776 free base

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of SGI-1776 free base

epigenetics
JAK-STAT

Isoform Comparison

Biological Activity

Target
  • Pim3

    Pim3, IC50:69 nM

  • Pim1

    Pim1, IC50:7 nM

  • Pim2

    Pim2, IC50:363 nM

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01239108 Relapsed/Refractory Leukemias PHASE1 WITHDRAWN 2025-04-12 MD Anderson Cancer Center, Hou... More >>ston, Texas, United States Less <<
NCT00848601 Prostate Cancer|Non-Hodgkins L... More >>ymphoma Less << PHASE1 TERMINATED 2025-10-10 UCLA, Los Angeles, California,... More >> 90095-1678, United States|Cancer Therapy Research Center, San Antonio, Texas, 78229, United States|Royal Marsden Hospital, Sutton, England, SM2 5PT, United Kingdom Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.47mL

0.49mL

0.25mL

12.33mL

2.47mL

1.23mL

24.67mL

4.93mL

2.47mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories